Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model

Mycobacterium-induced granulomas are the interface between bacteria and host immune response. During acute infection dendritic cells (DCs) are critical for mycobacterial dissemination and activation of protective T cells. However, their role during chronic infection in the granuloma is poorly unders...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 5; no. 7; p. e11453
Main Authors Schreiber, Heidi A, Hulseberg, Paul D, Lee, JangEun, Prechl, Jozsef, Barta, Peter, Szlavik, Nora, Harding, Jeffrey S, Fabry, Zsuzsanna, Sandor, Matyas
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 06.07.2010
Public Library of Science (PLoS)
Subjects
BCG
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mycobacterium-induced granulomas are the interface between bacteria and host immune response. During acute infection dendritic cells (DCs) are critical for mycobacterial dissemination and activation of protective T cells. However, their role during chronic infection in the granuloma is poorly understood. We report that an inflammatory subset of murine DCs are present in granulomas induced by Mycobacteria bovis strain Bacillus Calmette-guerin (BCG), and both their location in granulomas and costimulatory molecule expression changes throughout infection. By flow cytometric analysis, we found that CD11c(+) cells in chronic granulomas had lower expression of MHCII and co-stimulatory molecules CD40, CD80 and CD86, and higher expression of inhibitory molecules PD-L1 and PD-L2 compared to CD11c(+) cells from acute granulomas. As a consequence of their phenotype, CD11c(+) cells from chronic lesions were unable to support the reactivation of newly-recruited, antigen 85B-specific CD4(+)IFNgamma(+) T cells or induce an IFNgamma response from naïve T cells in vivo and ex vivo. The mechanism of this inhibition involves the PD-1:PD-L signaling pathway, as ex vivo blockade of PD-L1 and PD-L2 restored the ability of isolated CD11c(+) cells from chronic lesions to stimulate a protective IFNgamma T cell response. Our data suggest that DCs in chronic lesions may facilitate latent infection by down-regulating protective T cell responses, ultimately acting as a shield that promotes mycobacterium survival. This DC shield may explain why mycobacteria are adapted for long-term survival in granulomatous lesions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Current address: Department of Immunology, Loránd Eötvös University, Budapest, Hungary
Current address: Department of Medicine - Division of Rheumatology, University of California San Francisco, San Francisco, California, United States of America
Conceived and designed the experiments: HAS MS. Performed the experiments: HAS PDH JL. Analyzed the data: HAS MS. Contributed reagents/materials/analysis tools: JP PB NS ZF. Wrote the paper: HAS MS. Critical review and editing of manuscript: JSH.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0011453